Themis Medicare demonstrates mixed financial performance. While long-term compounded sales and profit growth are positive, recent trends show some inconsistencies.

Positive Profit Growth The company has demonstrated growth in profit over the long term.

Despite the positive long-term trends, there is a recent slowdown in profit growth. The TTM profit growth is only 3%.

OPM Concerns Operating Profit Margin (OPM) has shown a declining trend, indicating potential challenges in maintaining operational efficiency.

The OPM has decreased from 24% in Mar 2022 to 15% in TTM. This decline could be attributed to rising expenses or pricing pressures.

The capital efficiency and returns for Themis Medicare present a mixed outlook. While the company has demonstrated reasonable returns on capital employed (ROCE), there are concerns about the efficiency of working capital management.

ROCE Trends ROCE has fluctuated over the years.

Cash Conversion Cycle Issues The Cash Conversion Cycle (CCC) has been high, indicating inefficiencies in working capital management. This suggests that the company takes a long time to convert its investments in inventory and receivables into cash.

The CCC has been consistently above 150 days.

The financial health and prudence of Themis Medicare appear reasonable, with a stable debt-to-equity ratio and consistent dividend payout.

Debt Management The company's debt-to-equity ratio is under control, indicating a balanced capital structure.

Consistent Dividend Payout The company has been consistently sharing profits through dividends.

The strategic and operational indicators for Themis Medicare present a mixed assessment. While the company is investing in fixed assets for growth, there are concerns regarding working capital management.

Fixed Asset Management The company is strategically investing in fixed assets, as indicated by the increasing Gross Block.

Working Capital Management Issues Debtor Days have been increasing, indicating a slowdown in the collection of receivables.

Inventory Days are also high, indicating potential inefficiencies in inventory management.

The company's quarterly results show volatility in sales and profit growth, which indicates potential segment performance variability. This inconsistency could be due to various internal and external factors affecting different segments of the business.

The company's interest payments can affect profitability. This exposure may arise from borrowings denominated in foreign currencies or fluctuations in domestic interest rates.

As a pharmaceutical company, Themis Medicare is subject to stringent regulatory requirements. Increasing compliance costs could impact profitability.

There is no specific data available on contingent liabilities. Without this information, it is difficult to assess the full scope of potential future obligations.